Informations générales
750810814
Etat
75
Adresse
| CRS DES MARECHAUX FORT NEUF DE VINCENNES 75614 PARIS CEDEX 12 | Accès au plan |
Listes des essais cliniques en recrutement
| Etude | Statut | Dernière mise à jour | |
|---|---|---|---|
| NCT05668988 | A Phase 3, Open-Label, Randomized, Multi-Center Study of DZD9008 Versus Platinum-Based Doublet Chemotherapy as First-Line Treatment for Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer Harboring Epidermal Growth Factor Receptor Exon 20 Insertion Mutation | 27 février 2025 | |
| NCT04431999 | Evaluation of a Transfusion Therapy Using Whole Blood Versus Fractionated Blood Products in the Management of Coagulopathy in Patients Admitted to Hospital for Acute Traumatic Hemorrhage (T-STORHM) | 19 février 2025 | |
| NCT04626635 | A Phase 1/2 Study of REGN7075 (EGFRxCD28 Costimulatory Bispecific Antibody) in Combination With Cemiplimab in Patients With Advanced Solid Tumors (COMBINE-EGFR-1) | 01 février 2025 | |
| NCT06444087 | Patient's Perspective on the Evolution of Hidradenitis Suppurativa Burden After Secukinumab Initiation: a French Multicentric Prospective Observational Study (SPECTRA) | 15 janvier 2025 | |
| NCT05170204 | A Phase I-III, Multicenter Study Evaluating the Efficacy and Safety of Multiple Therapies in Cohorts of Patients Selected According to Biomarker Status, With Locally Advanced, Unresectable, Stage III Non-Small Cell Lung Cancer | 15 juin 2024 | |
| NCT05598684 | Assessment of Predictive Factors for Persistence of Treatment After Initiation of Adalimumab With a Biosimilar (Adalimumab Fresenius KaBI or Substitution of Reference Adalimumab With the Fresenius Kabi Adalimumab Biosimilar in Patients With Chronic Inflammatory Diseases (SAPHIR) | 15 juin 2024 | |
| NCT04115007 | Prostate-cancer Treatment Using Stereotactic Radiotherapy for Oligometastases Ablation in Hormone-sensitive Patients - a GETUG-AFU Phase III Randomized Controlled Trial (Oligo-PRESTO) | 15 juin 2024 | |
| NCT06031805 | a French Observational Prospective Multicenter Study of Adult Patients Treated in the Real-life Setting With Olaparib for the Treatment of Metastatic Castration-resistant Prostate Cancer (PROWESs) | 10 juin 2024 | |
| NCT04916613 | A Double-blind Randomised Phase III Trial Evaluating the Efficacy of ADT +/- Darolutamide in de Novo Metastatic Prostate Cancer Patients With Vulnerable Functional Ability and Not Elected for Docetaxel or Androgen Receptor Targeted Agents | 31 janvier 2024 | |
| NCT05689151 | Treating Atopic Dermatitis With Abrocitinib and Its Impact in Real Life: An Observational Cohort Study To Describe the Effectiveness of Abrocitinib in Patients With Moderate-to-Severe Atopic Dermatitis. (ADAIR) | 31 janvier 2024 | |
| NCT04042558 | A Multicentre Phase II, Open-label, Non-randomized Study Evaluating Platinum-Pemetrexed-Atezolizumab (+/- Bevacizumab) for Patients With Stage IIIB/IV Non-squamous Non-small Cell Lung Cancer With EGFR Mutations, ALK Rearrangement or ROS1 Fusion Progressing After Targeted Therapies (GFPC 06-2018) | 20 mars 2023 | |
| NCT04042558 | A Multicentre Phase II, Open-label, Non-randomized Study Evaluating Platinum-Pemetrexed-Atezolizumab (+/- Bevacizumab) for Patients With Stage IIIB/IV Non-squamous Non-small Cell Lung Cancer With EGFR Mutations, ALK Rearrangement or ROS1 Fusion Progressing After Targeted Therapies (GFPC 06-2018) | 20 mars 2023 | |
| NCT03887156 | Evaluation of a Donor Testing Kit for the Prediction of Acute GVHD in Patient Receiving a Peripheral Blood Stem Cells Allograft- Predictor 2 (Predictor2) | 20 mars 2023 | |
| NCT02355379 | Randomised Phase III Study Evaluating Adjuvant Chemotherapy After Resection of Stage III Colonic Adenocarcinoma in Patients of 70 and Over Intergroup Trial: Ffcd, Gercor, Gerico, Unicancer-gi (ADAGE) | 20 mars 2023 | |
| NCT02066454 | Evaluation of the Use of an Oral Direct Anti-Xa Anticoagulant, Apixaban, in Prevention of Venous Thromboembolic Disease in Patients Treated With IMiDs During Myeloma : a Pilot Study (MYELAXAT) | 20 mars 2023 | |
| NCT00984984 | Randomised Double-blinded Trial Comparing Efficacy and Safety of Methylprednisolone Per os Versus IV for the Treatment of Multiple Sclerosis Relapses (COPOUSEP) | 20 mars 2023 | |
| NCT00813345 | A Role for Light Therapy at Immediate Recovery From Short Duration Ambulatory Anesthesia to Prevent Dysregulation of Circadian Rest-Activity Rhythm in Patients Submitted to Colonoscopy. (LI-AMB) | 20 mars 2023 | |
| NCT04431999 | Evaluation of a Transfusion Therapy Using Whole Blood Versus Fractionated Blood Products in the Management of Coagulopathy in Patients Admitted to Hospital for Acute Traumatic Hemorrhage (T-STORHM) | 20 mars 2023 | |
| NCT00443339 | A Phase II Study of Darbepoetin Alpha in Myelodysplastic Syndromes (MSD) | 29 octobre 2022 | |
| NCT00224341 | 29 octobre 2022 |
Listes des établissements rattachés
| Finess | Etablissement | Catégorie | Adress |
|---|---|---|---|
| 130786742 | HIA LAVERAN | Hôpital des armées | 34 BD LAVERAN BP 60149 13384 MARSEILLE CEDEX 13 |
| 290000728 | HOPITAL INSTRUCTION DES ARMEES | Hôpital des armées | R COLONEL FONFERRIER 29240 BREST CEDEX 9 |
| 330781303 | HIA ROBERT PICQUE | Hôpital des armées | 351 RTE DE TOULOUSE CS 80002 33882 VILLENAVE D ORNON CEDEX |
| 570000596 | HIA LEGOUEST | Hôpital des armées | 27 AV DE PLANTIERES 57000 METZ |
| 690780093 | HIA DESGENETTES | Hôpital des armées | 108 BD PINEL 69003 LYON |
| 750019218 | CTRE INSTRUCTION INFIRMIERS ANESTHÉS. | Ecoles Formant aux Professions Sanitaires | 74 BD DE PORT ROYAL 75230 PARIS CEDEX 05 |
| 750821092 | SERVICE DE SANTE DES ARMEES | Etablissement de Soins du Service de Santé des Armées | 14 R SAINT DOMINIQUE 75007 PARIS |
| 830100574 | HIA SAINTE ANNE | Hôpital des armées | BD SAINTE ANNE BP 20545 83041 TOULON CEDEX 9 |
| 830100772 | HIA SAINTE ANNE MC ORATOIRE | Hôpital des armées | 313 CHE DE LA PAVEIGNE LES ROUTES 83062 TOULON CEDEX |
| 920006756 | CTSA DE CLAMART | Etablissement de Transfusion Sanguine | BP 410 92141 CLAMART CEDEX |
| 920120011 | HIA PERCY | Hôpital des armées | 101 AV HENRI BARBUSSE BP 406 92141 CLAMART CEDEX |
| 940120017 | HIA BEGIN | Hôpital des armées | 69 AV DE PARIS 94163 ST MANDE CEDEX |